"#$% " & # )* ; 6% )Z,%E ).I, Z+)6,

Size: px

Start display at page:

Download ""#$% " & # )* ; 6% )Z,%E ).I, Z+)6,"

Octavia Riley
5 years ago
Views:

1 ) ' ( %&!"#$ 0. * / -"+, + "! "#$% " & # './ "0 %1 ( )* +,-% % )* 8 %1 ( )* +,-% " # 8 +,#-9 = 5 )> 2< 31 ; : $9 *%&'(') azimakbarzadeh@pasteur.ac.ir 7 +':/. 6:<; ::1 2 3+, /89/ (,'/#0#+,-(.+,-+'/ = C'-7D,<A)= 68, $@)6/A)68,B@,'/,<A,(,4568,? >= 3+,-.#0?#"?#? : "G)H ;F +,456# (,'/#0#+,-686,>?5E ) C'-7D,< :6 :I4L+).P <; 7 I KLM(7,N 6HO 75).F,J ; )7 I %<(!) ; +,-+'/+,- 7 I7,(','/6,QRH :I6:C?$= 6: 76:):,':S T:,!/1 H6G L/F (,4).5/E )I4L+) 6:C"?68 7U ;F +,- 5= 5F W+'/. 1 <6,X;%$>(+,V, 6O U <68F [! 68 ;A,'ZH T 6C 6:86<.; 6/I[6^?. 6= 6 V!</;G)H,\4].0?"?@6C2 = <7. 6,4,E ) ;51!= 5 ).= 6,V,$@^@_@>= <??µg/ml. :+,- 5= 5;F A,Z'V'!<G)H I- IH+'/-6J. = 5Z ::" : = : :56:,H ;: ) G)H+,.I$ >µg/ml. ) G)H+,4.I0??µg/ml ; 6% )Z,%E ).I, Z+)6, ;F :,< <+'/a 6b Lc I 6Q 6 1!`H.+'/7 I 54 #3&!"#$!%& '()* #$'+!,& -./',0"1.2 $; 6/ )%<(!) 67 ;).F,J d(!)d+,-+'/ $" $"#"!

2 ; % D% ; % ; B C% # Oc,!b "#% U V % ; % "8% U C% )"H H H% H?#Q ; H% ; H% H B?H HAH CG#% P ZF. B ). B : ; % 6 3H9 # 9 % B? ( )X H B H H >H% H. )XH H% ; % 6 #H gh ; R "% 9%( B F % H,9 HH( Oc'b " Q Z1^ fd. h "H9 H #H "HD ; % "i ; H% IH-,% ;H- H H% ",9 : Hj% P H ; H% H 4"H. H 4". : 3 9 #D "#% >5Q H/ Oc2b HH% kx0 D% / B \0 = 6 % "# : % H H#6 H ; H% ;H a, O "/: 9E % "H/: H$Q HD% )"H#/= 8 CG#% l : * g ; ; ], O "H$D9 ]H9 H D% "% _ #% H" "8% B > >5Q % % #% ;H "H" ; H% 3H9 H 5H9 : H % ; P ; m% Oc7b "## )X HQ "HD "%ehumoralb I%/ # & >5Q B $Q = "% "#5 #, S 8 ] 9 H>nH/ H H H6 H "8% B > "#H/ ;H% 3H9 ]% 91-% B $Q ; % "0 K U C% ;# O"# 8 H` e DHi Q% (?5` :6(I4L+) Oco7b " % "D ]G% :+,-:+':/+,-7 I7,(','/6,QRH ;F -68 phv H #,H H D,d% ; H ; H% ;H H% "H,9 EFG9 <J7 H9 <J! IH ; H% H H6 H% IH -+H, % I# K L M )*%( -H 456 )* K L <<! 9 <J7 K HL NN7 9 <<! I K L B % +,#-9 = 5 OB H B ; % ; <<< I / P 1 9 )% " FFG% - H$Q "HB H 4H9 /): /B, H6 "#R ST9 ; % U C% >5Q #% O"H H$Q ; H% >"H##U C H% H5HVH "#H/ )"H# ;D% H HX!WNNNWNNN H$Q D%X NWNNNWNNN /H Z9"H6 "#H/ HD% ;/ ; % "H0 H O"#H/ H1V [ H5\% I1H/ U V HHQ ( O"H##H% >" D% X WNNNWNNN B H H-5 B H HL "HL% H% U C H% H U C H% "#/: _ 5` ;D% "#% ]^ T% H H H>;H ah, "H#/ 6 3H9 K "H M H I / K IV B Oc,b "/ = 8 B #H )" K %( B ) ; $#9 EHd% ( ST9 ]% I# "D $9 "L% % EH9 ; H% "#.1 6 WHO ]-9 %H*#/ ; H% ;D% B,0 ; O : B?` ]% # "D ( U C% cfhd. 4"#Hb %("H"$9 % "##% e.% )H B H> 8#% " Q% : >" H H6 ;H ;H O 6 /( "H##H% U C HV H ; H% H/0H H/9H 8 [ 6 /( ; % 6 /( ) B > 8#% % ;/ )" "B0! $

3 -/ )? N H6 4H9 HV HD% "H#9?6 = 1-H% ;H O H H% H: Ha>. - >: 5j = 1-%?0CH% f%hq H ; "D O]-, "L% % 5H H HA H% y 5 x0 cdsm-iv-trb = u1: %( r L9 #/ Diagnostic and statistical Manual of Mental H% H I1 H: H>/ B $Q H cdisorders H H I1 H: H 1 H?% H% H >. D,d% H cdysthymiab HF5z: " D, 4% "" > O""H Ha> #ID% * di = u1 : 5H H H H/>( B Hi 4 %9 H )"H _ CH9 H phv Q # B H B H$Q O"" * B * ){x% H "H- B H Hj5?% pv ; :, =?0C H% H x H0 "Ha> )H% ',7,<, % fdf% "D = %( Ocb " -/ ;FFG% " 48 ' H9 EH9 ( H = HS*(!) ). H% H "H H #H "HD B 6 = HS "HD #,H /=.1% = DQ% D,d% H> )"Hb "H H% O"- P > ( "HD E9 ]G% #D% c/ ) )" B 6H 7 = "% )" 48 F. 2N N / (H = S Ocb " -9 E9 "D / B H Gd : 49 = ^ E9 ]G% B LH _ 5CH9 cerythemab H H%. / -, cedemab 4 = HHH0 cindurationb >"HHH K H%( EH9 H/ ]H?.O"H "H# B 0 H>/ H H% H8,D% H>/ O" 48 - #H "HD - /B?.% * = %( *: Ocb " B?S B >%48 = HH%( HH HH +,9HH/ ;*H%H _ 5V D% X N B 5% H% H/ HcIH <o!n#h #% b I' # ;H ]%H H/ Hj%OB H )" 48 " ]H^0 ; % ( ( B A5` K HL qh9 HB /I ; % ; OB /( "H,9 IH0 +,#-9 = 5 Oco7b B H HD,d% ;H *:I4L :F,I![b f = "% b ; % ;D% % r L% & ( WHO P 4 c" 6 ]?. / s HL ;HD9 B H$Q OcJb "H 4H8 H5% ]-9 = "H%H ]."0 " _ 5V D,d% % B DQ EV #@ /B 9 X/ )% 3 "H% curinetoxicoloyiesb H/H H H8% H` H/ H5 U C% 4"6 #?% "#% H D,d% IV EV #@ O" B %1H #% = %( OB > 48 X/ ECG H- H/K H%( ]%H - Q Oc<b H H: H H# : K %( ]%H K /th ; )" a )" I` % r HF "" = u1: % Z1\H% "HH%H% H% H HIV 1 5Q canalgesicsb H/;v-% /)"## M 0 H/)"H## HG9 O" ) )X cantipyreticsb cimmunomodulatorsb H/_ 9 # H HQ% 961 V f#% 49 )X & ( >"H H% H w % - E % H ; H% B B Di % 5Q E r : )X pv Q ]G% B 6 = "% H caddiction severity index HASIb 6 = " H 5H H _ H5V H H/ :H HF.!'?0C% r : ; OcNb B > = ^ = 1-H% K HL B HX/ ( V B $> "B0!

4 ; % D% ; % ; B C% # Di% ]G9 ; % ; ]HG% )" : : " DHi % ]%H cdhi % s 5d%H = HSb E9 B Gd s $, = 0 /B L B 0 gh gh N H HF% H H HQ 4H9 H H H5: H9 e H5L% H/; ;H s 5d%H = HS OHH% EH9 * ; g ) ; % H9= "H% )9 9e X: 9@1% ; % # ;H / ( B 0 Di% O" "H^ W H H H H5: 9 / B = 1x6 * > )" % B H :H "H % K cs $, S b / H5: /; B? )" )"/% B & %( 2N N XH^ / % ]^ = HS 4H9 OB H > = H^ ;H EH9 ]?.<N CH% )> / % ]^0 s 5d% HX! )X N )>?5V O"% "#I"Q H B HQ H )H> H 2NN NN,' _ H99 H 4H H9 I H/)H> H/H% H,H5% ; 4>-% H*/ HO"H EH9 ", 5x6 2N NX^ )> / O" DQ%<N H( *: < 7 ' /)% H( "HF% H>)" ; B C% O"%( ]6 ELISA 5H H ; H% H )th )" ",9 H 4 )X ]5G9 89 Oc!b " 48 SPSS 600 µg/ml!n "#!)#)!"#C!#(!#" "# "$% & ' ( )*+ %", -$.! 100 µg/ml!n "#!(#* #!# #!# B H 12.5 µg/ml!n "#!)#) B 0g/ml!n!)#( $ % &',-. /01 2 3&'456% 7!8 9$:. 2 ; 2. <=&:0. A 2= D EF G % &' D EFG% IJ4,KG L.MJM% = 5NO. MP Q R = M4$ 3EST 0 "B0! $0

5 -/ )? "(# "() B)+) +*H *#( (#+ +*) H#+H +*) a "# $+ %"$ "# !/ :,R M,EQ. MM$. M0U V4 ""# )B )#+* "+() H#+B H+HC B) *#+) (+*" H# * (#+B "+H) )C H)+" +" "#* ##+( #+ # #( H#+ "+*" H C#+B C+H )( H)+B C+HH )# B *#+B B+(" "##( ##+ C+)C (#H ##+C (+C( C# H+* B+ #+( "#) ##+) "+B B)B )#+* )+#) *)C H)+" +H (# HB B+) #+) H#C C#+" +B "" #+B C+B) H) )#+H H+#" "# H+( B+" #+ )) )#+) +C" )C H)+" )+B) B)B )#+* # (#+* "+B #+" B# "+B #+B( "C( "+ #+C( B#) 0µg/ml XK@ <M S.D. +)µg/ml XK@ <M S.D. ##µg/ml XK@ <M S.D. (##µg/ml XK@ <M?KW OM OM"# OM"# OM"# *&'()%&!"#$a.3+,%2&&µg/ml'(%(/()(0%& -+&,1-&&µg/ml'./0%& -&&,+-.,+µg/ml' (=)> 7(!? (@AB (:5'() ("'$6 78)# 9:5';6<"' 4 )5 )+)H "+) #+(B S.D. ' DE5"$5"C "H H% K C% ; ;-% w?9 H H NW7 C " % K q% % ; H/ "HD,O" )" C% "F% ; H% xd " % K # 7W C uh H% K H = \O" )" D,d% H I )H> V e 5L% /)> X ' # ;% "D W' µg/ml mg/ml 4 )>, " ;D9 D,d% % H% H HX J #H ;H, "D NN 7W< C )" B?S % % ;9u O" ;D9 D,d% c2nn µg/mlb H )> % ;H H"H )"/H% EH9 ;H% "HD B 6 2! U C H% #H ]H?. B H,0 K H HS H$#9 OB H >= H^ 7W CH% H#D ; _ H.D% H H% P ;H H wh% s 5d%H 8 " 8 C% w?9 B C% ID% "0 16 % ' 9 gh HS ; )16O" )"/% E9 ]G% "HF% H DHi% s 5d%H = HS H ;H OB H" HQ # = D C% H% P ;H H w% s 5d% = S H% K _ 5. i Q K " =?6 )> I / Q : ;H " B ; /> O?1 Q K _ 5. i Q K " =?6 5x6 $> K 5> E50 4 = 0 H5: H9 H/;H B? g$9 B,0 OcI"Qb O 5: Systemic b H s H5d%H = S = " H Hd H, "H > A cadverse effects HA01% ]H. s 5d% = j9 OB " % pv HQ H B H" Q ( >)" $_ "B0!

6 ; % D% ; % ; B C% # 89 8 OB >. % ANOVA P P<NWNNb % #D%S V M <J; p<nwnnb C% cf=nnwj % ]F% O cf W< d.f.= d.f.= cf!27wj!w! d.f.= P<NWJ7b C% Q9 C% % ]F% S F "F% ].?1 )> ( % = " )> w% /) : ;# B Q9 % 9"" ]F% S 8 8#%?1 OcF=W! )> 2NN d.f= µg/ml J P<NWN7'b % C% )> ; %( F% B $ #D% C% S )" # * OcF J7WN d.f.= JJ P<NWNNb )" ) ]- I"Q V / "F% )> 49 ( "F% B w% qf /) ; OB )- " I#9 P, pv <N 9 " )"# % <N I"Q /> /} O" V ]% V ( } K / = " "/ % V / O - Z? D,d% % /)> 49 "". /} <N B % A <N 9u?9% N O" )"/% ; % ; ( 7W' _ 99 ( } )> O /)> cx^b } ( "F% # ;, "D / OcN,'b ]. /( H H HQ $Q DQ% % 9 ;H B H )- ; % ; m% Oco7b " Q $Q F%]. fq% ;Hq H9 ; ; ; % ; F% cnb B )" ( S HS ;H OH 5xH6 HQ >"B L * > "#H H. CH% ;9uH )> H#D H 5xH6 H*> % / O" 8 ; %9 O"%( Q )" E9 ; Q U V B 6!J = "% ) e = IH? I 9 pv % <N O"" = HS HQ H #?% > I )% B a> "D ]%H _ H5d% ;H O"H )"/H% H s 5d%H "H HA B HG9 I IV " % H H I "D " % * pv H = Hj9 H> n D,d% % O" )"/% )th H/H ( 8 _? ; % ; H( H/}H I"HQ O" )> / ; % ; B / X <N ; % "i.h phv <N H9 )H B H ; H% fdf% / )> / / ) O"/ % ""% H%O"H )"H H )H> H/ q H% % o]-h H H% IV ( } ;*% H % df $R I"Q OB )" ) <N )"H#/ H H% HdF <?1 X )"#/ K /HO"H B H HQ H B % B H > 48 D?V V )% 9 ( "F% u ; % "i ( /} " "0 ;H, O""H, # "D "F% r L9 ]. ~i ; %"i /( )H> # ;, "D N #D N ;H% "HD CH% H H/ O"H H }H "H )"/% (. } # OH " K # ;% "D /( = "H H wh?9 H aj9 )> / OB Q ( } "F% <N 9 ]^0 h %( = D,d% "B0! $B

7 -/ )? &( "!! )!) ") " # $!!% " "# &' ''"$ = "C = H5 '4 6 #$ G-$F 5 0*&#$ '%2&') =.KL'4 #/IJ2&%&& 4H9 #H B H ;%H 2N "HD 9uH H ( } O " K /)> HQ H* )H> B? )> %( ƒg, H = HX9 <N H, cp<nwnnbb H OB " Q )> ; ( /} ;H #,H %( D,d% h F% ; H% ; I0 9 R ",9 ; % ]^0 D,d%h a, B )" ",9 $Q H%( ]^ 0 D,d%h ; % ; H-/ ;H q H9 ; ; #, ;H HF% B )" ",9 S ; ; B? ; % ; F% = HS H H: H: ]HG9 IH?. ]H. H ;H ;H H wh% s 5d% & -D% ; ; U 1: ; % ; OB " )HH8 IH%/ H# H?5V H/ <N gh H ; H% ; H H HF% ;H# / U C H% H% 9 ]: ",9 e 5L% /; Q=6.KLPO'M$= N7 M H qh9 H >"HQ ;H ; S B H M ; % ; Ocb B > 48 H/ 4H>-% 2NN NN W' H E9 : : ]G9 ; % ;D%,5% IV ; w% ( = S >n/ O H H \ "D )% IV D,d% )% = S O" )"/% " Ij% )% B F % = H0 Q R K ]\% Q e X: ( HQ chd,d% H% H W Z"H0b " 5x6 * > >" E9 ]G% B 0 H/K #H H "HG% C H% ;9uH q HF = 1x H6 H* >OB H HQ H "H )H B C% ;9u /> H-9 s H#9 H% ;H H` H O" )"/% HF% ]H.?1 5Q /)> 49 /P > H/ ( ",9 G9 [ 6 ; % ; O + H( )th H( O" 49 ; % )t H ]. N # ;% ]?. $^ "B0!

8 ; % D% ; % ; B C% # H H6 B H ;H ;H OH% ; ( H*# B H,0 ; % U C% 6 "8% B > H "HF% ;, %*#/ O"#% >5Q HG9 _?H "F% ; % U C% "L% % H "HF% U C H% 9"" ]% 8 "" 6 *# B,0 8 8#% B $ )" )% K / ; ; O% ; % >"##U C% ; H% "F% U C%, = S ;H #D% B DQ O% f. S % H H$Q " "8% B > >5Q, "#/ % I? $Q D% /?, B / ) D% "D9 )" s Q #9 n/ P $#9 ; % ; % # P OB )" #H qhf OB H Hi0 IH0 )"H#/= 8 H H ]H% HVH H "H/:. : ; B y % ] ; O"/ = 8 : % H/ x H9% H$% H> H-/ phv ;H H DX "% X^ O@*y " ^ -/ 5% ;H H H H #H K HL O : 9u /( B? ; % )H>/ H HH( "HF% H H% )"/H%K /H I IV C% / H/ HH( "F% "$* k X0 B $Q ;H )XH H%OB % ; ( #H "HD )H%! "H0 ( / HH( "F% "% A O" % $ g c# ;:( "D )% b )%! "0,?. ]. K / M y co]-b ) K / #,H = HD,d% ]H^0 hh O"/% : #H 4H8 )"H## ;x H9 H )"H##"%,TH% H% H ; H% ;H D% */ )"H 8 ( "F%O"% ; % 6 ;%T9 ; % ; I?. ]. Z? EFG9 ; H ; H% HH( u "F%;# / O% ; % U C% "8%c]%b B > K / ;H O"#% ;%T9 ( ; "% % U CH% H "H8% B H> >H5Q H ; "CH. )H 3H9 H ]H% D% ; % S % " "8% B > >5Q ; H% H "HF% U C H% ")" ; = S ) _ L9 /; % ; % "i ( X Q P:6 XB!:8I$@UC@J#$V W$5STU'6 R- *R.&B O0[ -Z SJ=8K -%33 :6 XB!:8I$@UC@J #$ W$5 ] \X =Z# STU '6 R. -&R.-B O0[ %Z SC K -%1&:8Q P =5$@/X^ #$_ AC 54 5\X=Z#^ $"'$STU'6 R% -&R-1B O0[ -Z SXK -%1&XQ P:6 XB! :8I$@U "B0! "?

9 -/ )? )0-.&& =#$L a U\X=Z#:8C# ^ $"'$STU'6 R` -%1.:8Q P:6 $"#$ 2R..BO0[ %ZSK 5. Akbarzadeh A, Norouzian D, Farahmand B, Nouri Inanlou D. Rapid Latex agglutination inhibition reaction test formorphine in urine. Current Science. 2002; 83 (1): Akbarzadeh A, Mehraby M, Zarbakhsh M, Farzaneh H. Design and synthesis of a morphine-6-succinylbovine serum albumin hapten for vaccine development. Biotechnol Appl Biochem. 1999; 30 (pt 2): Akbarzadeh A, Norouzian D, Farhangi A, Mehrabi MR, Bakhtiari M, Afshar P, et al. Study of human therapeutic morphine vaccine; Safety and Immunogenicity. Asian journal of biochemistry. 2007; 2 (1): Svennerholm AM, Gothefors L, Sack DA, Bardhan PK, Holmgren J. Local and systemic antibody responses and immunological memory after immunization with cholera B subunit by different routes. Bull world Health organ. 1984; 62 (6): Gawin FH, Ellinwood EH. Cocaine and other stimulants: action, abuse and 10. treatment. N Engl J Med 1988; 318 (18) Kosten TR, Rosen M, Bond J, Settles M, Roberts JSC, Shields J, et al. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 2002; 20 (7): McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9 (3): Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, et al. Efficacy of a therapeutic cocainevaccine in rodent models. Nat Med. 1996; 2 (10): Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, Fox BS. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) 2000; 148 (3): Kosten T, Gawin FH, Silverman DG, Fleming J, Compton M, Jatlaw P, et al. Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology 1992; 7 (3): Jaffe JH, Cascella NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving psychopharmacology (Berl)1989; 97 (1): " "B0!

Parts Manual. EPIC II Critical Care Bed REF 2031

Parts Manual. EPIC II Critical Care Bed REF 2031 EPIC II Critical Care Bed REF 2031 Parts Manual For parts or technical assistance call: USA: 1-800-327-0770 2013/05 B.0 2031-109-006 REV B www.stryker.com Table of Contents English Product Labels... 4